ARCUTIS BIOTHERAPEUTIC
10.15
20-9月-24 15:59:59
15 分の遅延
株式
+0.01
+0.10%
本日の幅
9.78 - 10.31
ISIN
N/A
ソース
NASDAQ
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 5 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
29 4 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Appoints David Topper as Chief Financial Officer
10 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 4 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
28 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Promotes Todd Tucker to Chief Human Resources Officer
11 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
09 3 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 3 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
04 3 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Present at the TD Cowen 44th Annual Health Care Conference
29 2 2024 17:00:33 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Pricing of $150 Million Public Offering
28 2 2024 23:30:21 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
28 2 2024 16:10:00 提供 Nasdaq GlobeNewswire
-
28 2 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27 2 2024 05:50:12 提供 Nasdaq GlobeNewswire
-
Arcutis to Report Fourth Quarter and Full Year 2023 Financial Results
16 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 2 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Present at the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference
31 1 2024 08:00:00 提供 Nasdaq GlobeNewswire